Table 1.
Baseline clinical characteristics of studied subjects
| Baseline clinical characteristics | |
|---|---|
| Number of subjects |
17 |
| Age (years) |
24.35 ± 0.99 |
| BMI |
22.74 ± 0.58 |
| Systolic BP (mmHg) |
123.53 ± 2.70 |
| Diastolic BP (mmHg) |
77.94 ± 0.96 |
| Serum creatinine (μmol/L) |
86.76 ± 2.43 |
| Serum glucose (mmol/L) |
5.1 ± 0.09 |
| Red blood cells (T/L) |
5.1 ± 0.06 |
| Hemoglobin (g/dL) |
14.87 ± 0.15 |
| Hematocrite (%) |
43.76 ± 0.4 |
| Platelets (G/L) |
224.53 ± 9.62 |
| Leukocytes (G/L) |
5.75 ± 0.32 |
| Polynuclear neutrophils (G/L) |
2.87 ± 0.25 |
| Polynuclear eosinophils (G/L) |
0.16 ± 0.03 |
| Polynuclear basophils (G/L) |
0.02 ± 0.00 |
| Lymphocytes (G/L) |
2.15 ± 0.14 |
| Monocytes (G/L) |
0.54 ± 0.04 |
| SGOT (IU/L) |
25.65 ± 1.46 |
| SGPT (IU/L) |
25.89 ± 3.57 |
| CK (IU/L) |
137.88 ± 22.45 |
| GGT (IU/L) | 20.82 ± 1.63 |
Data are presented as the mean ± SEM. BMI: Body Mass Index; BP: blood pressure; SGOT: serum glutamic oxaloacetic transaminase; SGPT: serum glutamic-pyruvic transaminase, CK: Creatine kinase, GGT: Gamma-glutamyl transpeptidase.